U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

For patients on a 12-month plan, Hims offers a semaglutide injection for $199 a month. Ozempic and Wegovy carry high list prices of $935.77 and $1,349.02, respectively, for a month’s supply, according ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

Semaglutide and liraglutide — the key ingredients in Ozempic, Wegovy and similar drugs — are GLP-1 receptor agonists, which can delay food digestion if taken for extended periods of time.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

Share on Pinterest Getty Images/nortonrsx Wegovy (semaglutide) is an injectable prescription medication that’s approved by the Food and Drug Administration (FDA) for chronic weight management in ...

Novo Nordisk’s oral obesity pill, amycretin, showed faster weight loss than its blockbuster weekly injection for chronic weight management, Wegovy (semaglutide), in the phase I study.

A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...